IL17A and metabolic dysfunction-associated steatohepatitis: Whereas Wang et al. described a greater percentage of IL-17-producing CD4+ cells (considered as Th17 cells) in the peripheral blood of NASH patients compared to NAFL or healthy controls [84], Rau et al. did not find any differences [82].